rs1555091084
Positions:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP6_Very_Strong
The NM_000051.4(ATM):c.3403-15_3403-14insTA variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000535 in 1,556,992 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00021 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00057 ( 1 hom. )
Consequence
ATM
NM_000051.4 splice_polypyrimidine_tract, intron
NM_000051.4 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.133
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP6
Variant 11-108280980-T-TTA is Benign according to our data. Variant chr11-108280980-T-TTA is described in ClinVar as [Likely_benign]. Clinvar id is 490530.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.3403-15_3403-14insTA | splice_polypyrimidine_tract_variant, intron_variant | ENST00000675843.1 | NP_000042.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATM | ENST00000675843.1 | c.3403-15_3403-14insTA | splice_polypyrimidine_tract_variant, intron_variant | NM_000051.4 | ENSP00000501606 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000211 AC: 32AN: 151728Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
32
AN:
151728
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000556 AC: 129AN: 231976Hom.: 0 AF XY: 0.000548 AC XY: 69AN XY: 125826
GnomAD3 exomes
AF:
AC:
129
AN:
231976
Hom.:
AF XY:
AC XY:
69
AN XY:
125826
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000570 AC: 801AN: 1405146Hom.: 1 Cov.: 31 AF XY: 0.000564 AC XY: 395AN XY: 700236
GnomAD4 exome
AF:
AC:
801
AN:
1405146
Hom.:
Cov.:
31
AF XY:
AC XY:
395
AN XY:
700236
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000211 AC: 32AN: 151846Hom.: 0 Cov.: 0 AF XY: 0.000242 AC XY: 18AN XY: 74258
GnomAD4 genome
AF:
AC:
32
AN:
151846
Hom.:
Cov.:
0
AF XY:
AC XY:
18
AN XY:
74258
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Aug 15, 2023 | - - |
Breast and/or ovarian cancer Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Dec 19, 2022 | - - |
ATM-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 10, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Familial ovarian cancer Benign:1
Benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The ATM c.3403-15_3403-14insTA variant was identified in the following databases: dbSNP (ID: rs3218681) “With Benign, other allele”, and in control databases in 144695 (40554 homozygous) of 258930 chromosomes at a frequency of 0.6 (Genome Aggregation Consortium Feb 27, 2017), falling on 3 transcripts with a population breakdown of: South Asian in 16377 (5070 homozygous) of 26642 chromosomes (freq: 0.6), European (Finnish) in 14916 (4483 homozygous) of 24280 chromosomes (freq: 0.6), Latino in 19186 (5780 homozygous) of 31316 chromosomes (freq: 0.6), Ashkenazi Jewish in 5646 (1697 homozygous) of 9232 chromosomes (freq: 0.6), Other in 3528 (1050 homozygous) of 5964 chromosomes (freq: 0.6), European (Non-Finnish) in 67483 (18810 homozygous) of 119980 chromosomes (freq: 0.6), African in 10689 (2402 homozygous) of 23444 chromosomes (freq: 0.5), and East Asian in 6870 (1262 homozygous) of 18072 chromosomes (freq: 0.4). The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. - |
Hereditary cancer-predisposing syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Jun 16, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at